mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0039 |
0.9 |
mRNA |
TGX221 |
CTRPv2 |
pan-cancer |
AAC |
0.004 |
0.9 |
mRNA |
fingolimod |
CTRPv2 |
pan-cancer |
AAC |
0.0038 |
0.9 |
mRNA |
silmitasertib |
CTRPv2 |
pan-cancer |
AAC |
0.0037 |
0.9 |
mRNA |
avicin D |
CTRPv2 |
pan-cancer |
AAC |
-0.0051 |
0.9 |
mRNA |
GDC-0879 |
CTRPv2 |
pan-cancer |
AAC |
0.0033 |
0.9 |
mRNA |
gossypol |
CTRPv2 |
pan-cancer |
AAC |
0.0035 |
0.9 |
mRNA |
BRD-K02251932 |
CTRPv2 |
pan-cancer |
AAC |
0.0036 |
0.9 |
mRNA |
decitabine:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0026 |
0.9 |
mRNA |
LY-2183240 |
CTRPv2 |
pan-cancer |
AAC |
-0.0028 |
0.9 |